Navigation Links
Medarex Announces 2008 Third Quarter Financial Results
Date:10/30/2008

process

technology - 6,900 - 6,900

Impairment loss on investments - - - 2,141

Equity in net loss of affiliate 2,813 - 8,144 -

Gain on sale of Genmab stock - - (151,834) (152,143)

Non-GAAP Net loss $(37,430) $(36,295) $(119,537) $(104,757)

GAAP Net income (loss) per

share,

basic $(0.36) $(0.41) $0.04 $0.14

diluted $(0.36) $(0.41) $0.04 $0.14

Non-GAAP Net loss per share,

basic and diluted $(0.29) $(0.29) $(0.93) $(0.83)

Shares used in computing

basic and diluted GAAP net

income (loss) per share and

Non-GAAP net loss per share 128,335 127,125 128,064 126,200

(1) In management's view, the operations of Celldex prior to its merger

with AVANT Immunotherapeutics, Inc. (now Celldex Therapeutics, Inc.),

effective March 7, 2008, are not necessarily indicative of, or

directly attributable to, Medarex's continuing operations. Celldex's

operations relate primarily to the research, development and

commercialization of therapeutic vaccines, which is outside the scope

of Medarex's core business operations.

(2) For the three and nine months ended September 30, 2008, Medarex

incurred $5.4 million and $16.7 million in non-cash stock compensation

expense, of which $2.6 million and $7.4 million are included in

research and development expenses and $2.8 million and $9.3 million,

respectively, are included in general and administrative expenses.

Stock compensation expense includes costs associated with stock

awards, including stock options which were recorded in accordance with

the provisions of FAS 1
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... RALEIGH, N.C. , Aug. 20, 2014 /PRNewswire/ ... clinical research services located in Raleigh, ... Bradford Evans as Vice President of ... Administration, Brad will oversee all corporate processes, including ... to joining Clintrax Global, Brad worked as an ...
(Date:8/20/2014)... have it that American Indians largely were wiped out ... and tuberculosis brought to the New World by European ... million people lived in the Americas shortly before Europeans ... by European diseases., But new research led by anthropological ... Krause of the University of Tubingen in Germany indicates ...
(Date:8/20/2014)... , Aug. 20, 2014 Neurotrope, ... host a conference call to provide an update ... p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and ... Live web cast: www.neurotropebioscience.com , under "Investor Relations"The ... after completion through September 2, 2014 at (888) ...
(Date:8/20/2014)... , Aug. 20, 2014  Decision Resources Group finds that the ... Russia , India and ... in 2013, roughly equal to the size of the ... BRIC market will experience much faster growth as a result of ... Other key findings from Decision Resources Group,s coverage of ...
Breaking Biology Technology:Clintrax Global, Inc. Announces Addition to Executive Team 2Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3Neurotrope To Host Conference Call 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3
... in Nature Nanotechnology questions whether industry, government ... technologies to ensure the safe and responsible development of ... the 12 "late lessons from early warnings," published by ... emerging field of nanotechnology. EEA,s "lessons" are drawn ...
... July 21 Zenobia Therapeutics, Inc.,(Zenobia) announced today ... La Jolla, California. Zenobia was founded June 1, ... laboratory and office facilities,on July 1. The Zenobia ... biology and fragment-based lead discovery (FBLD)., Zenobia ...
... July 21 Abingdon Life Sciences,announces the formal ... located at 5963 La Place Court, Suite 107, ... Palomar Airport. Abingdon Life Sciences,Inc. is a first-in-class ... providing drug and device companies with,superior services based ...
Cached Biology Technology:Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company 2Abingdon Life Sciences, Inc. Announces Opening of Office in Carlsbad, Ca. 2
(Date:8/20/2014)... a John and Rebecca Moores Professor of Biology and Biochemistry ... in the International Society for the Study of the Origin ... members two from the U.S., one from France and ... are elected every three years, and 36 have been named ... 20 countries, the ISSOL includes researchers from disciplines as varied ...
(Date:8/20/2014)... 20, 2014 /CNW/ -  Issue Serious ... quickly become life threatening for some children.    ... million Canadians have food allergies and this number may be ... children are estimated to have food allergies.  ... irritations and hives to breathing difficulties and loss of consciousness. ...
(Date:8/20/2014)... 19, 2014 -- Bay Area Lyme Foundation, which aims ... to cure, applauds new research published in an upcoming ... and Tick-borne Diseases . The findings show that ... active throughout the year, making the threat of Lyme ... California Department of Public Health (CDPH) Vector-borne Disease Section ...
Breaking Biology News(10 mins):UH professor named fellow by International Astrobiology Society 2Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3
... German . , The sea-ice is getting thinner ... the Arctic Ocean,Bremerhaven, September 13, 2007. Large areas of ... equating to an approximate 50 percent thinning as compared to ... latest Alfred-Wegener-Institute for Polar and Marine Research in the Helmholtz ...
... -- Peering at microscopic changes within the retina, scientists in ... New York City, have discovered a key mechanism driving eye ... article of a recent edition of Cell, the team says ... rod cells regenerate themselves. The retina uses two ...
... WASHINGTON, Sept. 12 J. Michael McConnell, Director ... Secretary of Defense,for Intelligence will provide valuable insights ... vision for implementing the United States,Intelligence Community 100 ... the Conference: The Office of the Director ...
Cached Biology News:The sea ice is getting thinner 2The sea ice is getting thinner 3The sea ice is getting thinner 4Scientists eye secrets of retinal regeneration 2
RatTRAPTM Assay is a solid-phase immunofixed enzyme activity assay for the determination of osteoclast-derived TRACP 5b activity in rat serum....
... contains a unique β-agarose digesting enzyme developed ... intact DNA and RNA from low melting ... TAE, TBE, MOPS, or phosphate buffers. The ... TAE, TBE, MOPS, and phosphate electrophoresis buffers ...
... (TdT) is an intracellular marker normally present ... minor subpopulation of bone marrow prelymphocytes. Elevated ... of TdT cells are found to be ... Presence of TdT thus provides a useful ...
Recombinant Ovine IFN Tau. Active on sheep, cow, human and mouse cells. Activity: 5.7 x 10 7 u/mg...
Biology Products: